Methylcobalamin deficiency type cblDv1

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:308380OMIM:277410E72.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Methylcobalamin deficiency type cblDv1 is an extremely rare inherited metabolic disorder that affects how the body processes vitamin B12 (cobalamin). Specifically, it disrupts the production of methylcobalamin, one of the two active forms of vitamin B12 that the body needs. This active form is essential for an enzyme called methionine synthase, which plays a key role in converting the amino acid homocysteine into methionine. When this process does not work properly, homocysteine builds up in the blood and urine (a condition called homocystinuria), while methionine levels become abnormally low. The disease is caused by mutations in the MMADHC gene. In the cblDv1 variant, only the methylcobalamin pathway is affected, while the other cobalamin pathway (adenosylcobalamin production) remains intact. This distinguishes it from other cblD subtypes that may affect both pathways or only the adenosylcobalamin pathway. Symptoms typically appear in infancy or early childhood and can include developmental delays, feeding difficulties, megaloblastic anemia (a type of anemia where red blood cells are abnormally large), neurological problems such as seizures and low muscle tone, and failure to thrive. Without treatment, the condition can lead to significant intellectual disability and progressive neurological damage. Treatment generally involves supplementation with hydroxocobalamin (a form of vitamin B12) and betaine to help lower homocysteine levels. Early diagnosis and prompt treatment are critical to improving outcomes, though the long-term prognosis can vary depending on how early treatment begins and how well the body responds.

Also known as:

Key symptoms:

Developmental delayMegaloblastic anemia (large, abnormal red blood cells)Low muscle tone (floppy baby)SeizuresFeeding difficultiesFailure to thrive or poor weight gainIntellectual disabilityElevated homocysteine in blood and urineLow methionine levels in bloodLethargy or excessive sleepinessPoor growthBehavioral changesWalking or movement difficulties

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Methylcobalamin deficiency type cblDv1.

View clinical trials →

No actively recruiting trials found for Methylcobalamin deficiency type cblDv1 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Methylcobalamin deficiency type cblDv1 community →

No specialists are currently listed for Methylcobalamin deficiency type cblDv1.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Methylcobalamin deficiency type cblDv1.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Methylcobalamin deficiency type cblDv1Forum →

No community posts yet. Be the first to share your experience with Methylcobalamin deficiency type cblDv1.

Start the conversation →

Latest news about Methylcobalamin deficiency type cblDv1

No recent news articles for Methylcobalamin deficiency type cblDv1.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is my child's condition based on the specific genetic mutations found?,What is the recommended treatment plan, and how often will injections be needed?,How frequently should blood tests be done to monitor homocysteine and methionine levels?,What developmental therapies should we start, and how soon?,Are there any signs or symptoms I should watch for that would require emergency care?,What is the expected long-term outlook for my child with treatment?,Should other family members be tested for carrier status, and what are the implications for future pregnancies?

Common questions about Methylcobalamin deficiency type cblDv1

What is Methylcobalamin deficiency type cblDv1?

Methylcobalamin deficiency type cblDv1 is an extremely rare inherited metabolic disorder that affects how the body processes vitamin B12 (cobalamin). Specifically, it disrupts the production of methylcobalamin, one of the two active forms of vitamin B12 that the body needs. This active form is essential for an enzyme called methionine synthase, which plays a key role in converting the amino acid homocysteine into methionine. When this process does not work properly, homocysteine builds up in the blood and urine (a condition called homocystinuria), while methionine levels become abnormally low.

How is Methylcobalamin deficiency type cblDv1 inherited?

Methylcobalamin deficiency type cblDv1 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Methylcobalamin deficiency type cblDv1 typically begin?

Typical onset of Methylcobalamin deficiency type cblDv1 is infantile. Age of onset can vary across affected individuals.